MedPath
NMPA Approval

Repaglinide Tablets

国药准字H20123055

October 12, 2021

国药准字H20123055

Drug Information

瑞格列奈片

康瑞

片剂

1mg

化学药品

October 12, 2021

Company Information

Applicant Company

天津自贸试验区(空港经济区)西七道18号

Manufacturing Company

天津自贸试验区(空港经济区)西七道18号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

瑞格列奈片 - NMPA 批准文号 | MedPath